#JPM23: When will the IPO win­dow open? What terms are star­tups get­ting? Here's what to ex­pect from cap­i­tal mar­kets this year

Ex­ec­u­tive Ed­i­tor Drew Arm­strong sat down with Bay­er’s busi­ness de­vel­op­ment leader Mar­i­anne De Backer, PwC’s phar­ma deals chief Roel Van den Akker, and Sofinno­va In­vest­ments Gen­er­al Part­ner Ma­ha Katabi to talk about the IPO en­vi­ron­ment, trends in pub­lic and pri­vate fundrais­ing, how ne­go­ti­a­tions be­tween com­pa­nies have changed and where cap­i­tal mar­kets are head­ed in 2023. This tran­script has been edit­ed for brevi­ty and clar­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER